Nav: Home

£10 million for new math centers to tackle life-threatening diseases

December 16, 2015

Life Sciences Minister George Freeman today (16 December) announced £10 million investment in five new research centres around the UK that will explore how mathematics and statistics can help clinicians to tackle serious health challenges such as cancer, heart disease and antibiotic resistant bacteria.

Located at universities in Liverpool, Glasgow, London, Cambridge and Exeter, researchers at the centres will develop new tools from predictive mathematical models to enable earlier diagnosis of chronic diseases such as epilepsy, and new systems to make clinical imaging more accurate and efficient.

Funded by the Engineering and Physical Sciences Research Council (EPSRC), the centres will enable mathematicians and statisticians to work closely with healthcare planners, clinicians, policy makers and industry partners across the UK to deliver high quality, multidisciplinary research that will help overcome some of the big challenges facing the NHS.

George Freeman, Minister for Life Sciences, said: "Maths and statistics aren't the first sciences that come to mind when we talk about healthcare innovation. But they have a very important part to play in developing 21st century solutions to the challenges facing clinicians every day in the NHS. That's why we are investing £10 million in five new Mathematical Sciences in Healthcare Research Centres up and down the country, to help doctors gain a better understanding of diseases, make faster diagnoses and plan better, more targeted treatment for patients."

Professor Philip Nelson, EPSRC's Chief Executive, said: "Maths research provides the foundation for so much of science and engineering, and new technologies, but this often goes unrecognised by those who benefit from results. These five new Mathematical Sciences in Healthcare Centres will lead the way in developing mathematical and statistical modelling for predicting the progression of diseases both in individuals and populations, as well as planning treatment strategies. The Centres will help us deal with the clinical and economic challenges facing the UK's healthcare system as the population ages."

The Centres are:

EPSRC Centre for Predictive Modelling in Healthcare - led by Professor John Terry (University of Exeter) - EP/N014391/1

The Centre brings together a world leading team of mathematicians, statisticians and clinicians with a range of industrial partners, patients and other stakeholders to focus on the development of new methods for managing and treating chronic health conditions using predictive mathematical models. As our population ages, the number of people living with a chronic disorder is forecast to rise dramatically, increasing an already unsustainable financial burden of healthcare costs on society and potentially a substantial reduction in quality of life for the many affected individuals. Critical to averting this are early and accurate diagnoses, optimal use of available medications, as well as new methods of surgery. The Centre will facilitate these through developing mathematical and statistical tools necessary to inform clinical decision making on a patient-by-patient basis which could lead to a revolution in diagnosis of epilepsy by enabling diagnosis from markers that are present even in the absence of seizures; reducing time spent in clinic and increasing accuracy of diagnosis. Indeed it may even make diagnosis in the GP clinic a reality.

EPSRC Centre for New Mathematical Sciences Capabilities for Healthcare Technologies - led by Professor K Chen (University of Liverpool) - EP/N014499/1

The Centre brings together a large and multidisciplinary team of applied and pure mathematicians and statisticians together with healthcare researchers, clinicians and industrialists, collaborating with 15 HEIs and 40 NHS trusts plus other industrial partners to address several key challenges in healthcare. These include improving our understanding of the interaction of cells and tissues, essential to improve treatment strategies for cancer, developing better algorithms for improved medical image processing to allow earlier and more accurate diagnosis and developing mathematical models to develop our understanding of the emergence of antibiotic resistance.

EPSRC Centre for Multiscale Soft Tissue Mechanics - with application to heart & cancer - led by Professor Raymond Ogden (University of Glasgow)-EP/N014642/1

The Centre brings together a world-leading interdisciplinary team focused on developing advanced mathematical models for understanding the development of two of the highest mortality diseases; cancer and cardiac disease. For example, the computational modelling of cancer will give surgeons greater insight into the specific properties of a breast cancer in a given patient, while research on changes in the heart following heart attacks will provide cardiologists with much more detailed information on heart injury and function, and greater understanding of individual patients' risk of heart failure and response to treatment, leading to more-refined patient-specific therapy.

EPSRC Centre for Mathematics of Precision Healthcare - led by Professor Mauricio Barahona (Imperial College London) - EP/N014529/1

The Centre aims to bring about improvements in precision healthcare (an approach that takes into account individual variability in genes, environment, and lifestyle from the individual to the population levels) which can have transformative effects on the UK's health and quality of life. The tools developed will enrich decision making in healthcare so that patients receive the care they need and want while minimising the inefficiencies of inadequate patient stratification. A population-level approach, complementing studies of patient journeys, will allow us to move towards truly joined up clinical intervention and improvements in national public health strategy.

EPSRC Centre for Mathematical and Statistical Analysis of Multimodal Clinical Imaging - led by Professor John Aston (University of Cambridge) - EP/N014588/1

In this new age of Big Data, traditional boundaries between applied maths and statistics need to be torn down. This Centre aims to achieve synergies between applied mathematics and statistics through a focus on the analysis of clinical imaging, particularly that arising in neurological, cardiovascular and oncology imaging. Current image analysis is based on techniques such as manual segmentation and technician reading of scans. The methodologies developed in this Centre will look to directly automate many of these steps. This will allow considerably greater flexibility in the types of clinical questions that can be addressed using populations of images.
-end-
For further information please contact the EPSRC Press Office on 01793 444 404 or email pressoffice@epsrc.ac.uk

Notes for Editors:

The Engineering and Physical Sciences Research Council (EPSRC)

As the main funding agency for engineering and physical sciences research, our vision is for the UK to be the best place in the world to Research, Discover and Innovate.

By investing £800 million a year in research and postgraduate training, we are building the knowledge and skills base needed to address the scientific and technological challenges facing the nation. Our portfolio covers a vast range of fields from healthcare technologies to structural engineering, manufacturing to mathematics, advanced materials to chemistry. The research we fund has impact across all sectors. It provides a platform for future economic development in the UK and improvements for everyone's health, lifestyle and culture.

We work collectively with our partners and other Research Councils on issues of common concern via Research Councils UK. http://www.epsrc.ac.uk

Engineering and Physical Sciences Research Council

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...